DSPE-PEG-NHS, MW 2000

DSPE-PEG-NHS, MW 2000 is a PEG-modified phospholipid derivative that can be used to prepare liposomes. DSPE-PEG-NHS, MW 2000 is commonly employed as a linker molecule for the surface modification of liposomes to confer targeting capabilities. DSPE-PEG-NHS, MW 2000 can be used in the study of drug delivery[1][2].

Product Specifications

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Liposome

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/dspe-peg-nhs-mw-2000.html

Purity

98.0

Solubility

DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

CCCCCCCCCCCCCCCCCC(OC[C@@H](OC(CCCCCCCCCCCCCCCCC)=O)COP(OCCNC(OCCNC(CCC(ON1C(CCC1=O)=O)=O)=O)=O)(O)=O)=O.[n]

Molecular Weight

2000 (Average)

Precautions

H302, H315, H319, H335

References & Citations

[1]Zhang X, et al. The study on brain targeting of the amphotericin B liposomes. J Drug Target. 2003 Feb;11 (2) :117-22.|[2]Zhao W, et al. DSPE-PEG Modification of α-Conotoxin TxID. Mar Drugs. 2019 Jun 8;17 (6) :342.